$210.24
3.17%
NYSE, Apr 21, 08:15 pm CET
ISIN
US50540R4092
Symbol
LH

Laboratory Stock price

$217.12
-23.31 9.70% 1M
+1.99 0.93% 6M
-12.20 5.32% YTD
+17.15 8.58% 1Y
-12.36 5.38% 3Y
+89.53 70.17% 5Y
+110.24 103.15% 10Y
NYSE, Closing price Thu, Apr 17 2025
-3.45 1.56%
ISIN
US50540R4092
Symbol
LH
Sector

Key metrics

Market capitalization $18.17b
Enterprise Value $23.93b
P/E (TTM) P/E ratio 24.57
EV/FCF (TTM) EV/FCF 21.84
EV/Sales (TTM) EV/Sales 1.84
P/S ratio (TTM) P/S ratio 1.40
P/B ratio (TTM) P/B ratio 2.25
Dividend yield 1.33%
Last dividend (FY24) $2.88
Revenue growth (TTM) Revenue growth 0.83%
Revenue (TTM) Revenue $13.01b
EBIT (operating result TTM) EBIT $1.14b
Free Cash Flow (TTM) Free Cash Flow $1.10b
Cash position $1.52b
EPS (TTM) EPS $8.84
P/E forward 17.31
P/S forward 1.31
EV/Sales forward 1.72
Short interest 2.93%
Show more

Is Laboratory a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Laboratory Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Laboratory forecast:

18x Buy
78%
5x Hold
22%

Analyst Opinions

23 Analysts have issued a Laboratory forecast:

Buy
78%
Hold
22%

Financial data from Laboratory

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
13,009 13,009
1% 1%
100%
- Direct Costs 9,641 9,641
0% 0%
74%
3,368 3,368
4% 4%
26%
- Selling and Administrative Expenses 1,587 1,587
13% 13%
12%
- Research and Development Expense - -
-
-
1,782 1,782
3% 3%
14%
- Depreciation and Amortization 644 644
9% 9%
5%
EBIT (Operating Income) EBIT 1,138 1,138
0% 0%
9%
Net Profit 746 746
78% 78%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Stock News

Neutral
GlobeNewsWire
10 days ago
Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Genetic Screening Testing for Preventive Health Market - A Global and Regional Analysis: Focus on Test Type, Technology, Application, End User and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The market for genetic screening testing in preventive health has been experiencing...
Neutral
PRNewsWire
11 days ago
BURLINGTON, N.C. , April 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.
Neutral
PRNewsWire
19 days ago
Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease BURLINGTON, N.C. , April 2, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide launch of its pTau-217/Beta Amyloid 42 Ratio, a powerful new blood-based biomark...
More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office United States
CEO Adam Schechter
Employees 70,000
Founded 1971
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today